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Aging of hematopoietic stem cells (HSCs) is accompanied by diminished functional potential. Wang
et al. now provide evidence for an HSC-specific differentiation checkpoint mediated by the
transcription factor BATF, which limits self-renewal of HSCs in response to the accumulation of
DNA damage.Age-associated functional decline in
tissue-specific adult stem cells is thought
to contribute to the loss of tissue homeo-
stasis and age-related pathophysiology.
Aging in the hematopoietic system is
associated with diminished regenerative
potential, reduced immune competence,
and predisposition to myelogenous dis-
ease, including an elevated incidence
of myelodysplastic syndrome (MDS) and
myeloid leukemia (Rossi et al., 2008).
Evidence suggests that aging of hemato-
poietic stem cells (HSCs) may be central
to the onset of these pathophysiologies.
The functional potential of HSCs changes
with age with old HSCs exhibiting a re-
duced capacity to regenerate the hema-
topoietic system and an altered lineage
potential wherein lymphoid differentiation
diminishes in favor of myeloid differentia-
tion through a number of cell-autonomous
mechanisms, including DNA-damage ac-
cumulation (Rossi et al., 2007; Ru¨be et al.,
2011), clonal dominance of myeloid-
biased HSCs (Beerman et al., 2010;
Morita et al., 2010), and alterations in line-
age specification programs (Chambers
et al., 2007; Rossi et al., 2005). To date,
a direct connection has not been made
between the accrual of DNA damage in
HSCs and their differentiation potential.
That DNA damage in stem cells might
influence differentiation potential was first
demonstrated in melanocyte stem cells
(MSCs), in which irreparable genotoxic
stress induces premature differentiation
into mature melanocytes (Inomata et al.,
2009). Extending this paradigm to the
hematopoietic system, Wang et al. (2012)
now identify a surprising mechanistic linkbetween the DNA-damage response
(DDR) in HSCs and their differentiation
potential that is mediated by Batf (basic
leucine zipper transcription factor, ATF-
like).
Batf belongs to the AP-1 transcription
factor superfamily and induces differenti-
ation in cells of lymphoid andmyeloid line-
ages in a Stat3-dependent manner fol-
lowing cytokine stimulation (Liao et al.,
2011). However, a role in regulating the
functional potential of primitive hemato-
poietic stem and progenitor cells (HSPCs)
had not been shown. Using an in vivo
small hairpin RNA-mediated knockdown
to identify genes that regulate HSCs in
a setting of telomerase deficiency (leading
to induction of DDR), Wang et al. identify
four candidate genes. Of these, only Batf
specifically exerts its effects in the setting
of telomere attrition. Moreover, Batf is
the most enriched target of their screen.
Based on these findings, the authors
hypothesize that Batf might be involved
in restricting the self-renewal of HSCs in
the telomerase-deficient background.
This view is then supported by ex-
periments in which serial transplantation
of telomerase-deficient HSCs selects for
Batf knockdown, though interestingly,
loss of Batf does not appear to affect
wild-type HSCs. Experiments with irradi-
ated Batf-deficient mice reveal that loss
of Batf confers a selective advantage to
HSCs due to an attenuation of the DDR.
Strikingly, HSCs lacking Batf exhibit evi-
dence of persistent DNA damage, con-
sistent with what has been reported in
HSCs isolated from old mice and elderly
humans (Rossi et al., 2007; Ru¨be et al.,Cell 12011). Indeed, when the authors exam-
ined aged mice, they found that both
Batf mRNA and protein are increased in
HSCs. These results are consistent with
age-associated DNA-damage accumula-
tion in HSCs (Rossi et al., 2007; Ru¨be
et al., 2011), thus leading to an increase
in Batf.
In exploring the relationship between
Batf and p53, a central mediator of the
DNA-damage response, the authors find
that Batf is required for p53 activation
and induction of p53-target genes in re-
sponse to DNA damage. This helps ex-
plain why Batf-deficient HSCs exhibit im-
proved maintenance and function even
in the presence of DNA damage. Further-
more, the current study integrates the
cytokine signaling/microenvironmental
cues to DNA-damage-induced loss of
stem cell function by demonstrating that
DNA-damage-associated Batf induction
requires G-CSF/Stat3 signaling.
Diminished adaptive immune compe-
tence due to deficiencies in B and T
lymphocytes is perhaps the most pene-
trant attribute of the aged hematopoietic
system. Although loss of lymphoid poten-
tial is a cell-autonomous attribute of HSC
aging, the precise mechanisms under-
lying this have remained elusive. Re-
cently, however, distinct HSC subsets
have been identified that shed some
light on this issue. Based on differential
expression of CD150, two studies re-
cently reported that long-term repopulat-
ing HSCs could be subfractionated into
two functionally distinct subsets, one of
which is more predisposed to lymphoid
differentiation (CD150lo), whereas the48, March 2, 2012 ª2012 Elsevier Inc. 847
Figure 1. A Differentiation Checkpoint in HSCs Mediated by Batf
(Left) Under steady-state conditions, the established homeostasis between lymphoid-biased (CD150lo)
and myeloid-biased (CD150hi) hematopoietic stem cells (HSCs) self-renews (solid curved arrows) and
gives rise to lymphoid and myeloid progeny.
(Right) Under genotoxic stress/telomere attrition, DNA damage leads to upregulation of Batf that mediates
a differentiation checkpoint in which lymphoid specification gene programs are upregulated in HSCs to
induce lymphoid differentiation. This primarily occurs within the lymphoid-biased CD150lo HSCs, which
are subverted from self-renewing divisions (open curved arrows).other is more predisposed to myeloid
differentiation (CD150hi) (Beerman et al.,
2010; Morita et al., 2010). With advanced
age, the CD150hi myeloid-biased HSCs
predominate in the HSC pool, which in
part helps to explain the age-associated
loss of lymphoid potential. The study
by Wang et al. now provides important
mechanistic insights that may explain
the selective loss of HSC lymphoid poten-
tial during aging. Using an elegant in-
terleukin-7 receptor-reporter system, the
researchers find that lymphoid-biased
CD150lo HSCs are induced to lymphoid
differentiation in response to DNA da-
mage through upregulation of lymphoid
specification genes (Figure 1). By commit-
ting to differentiate, the lymphoid-biased848 Cell 148, March 2, 2012 ª2012 Elsevier IHSCs forgo self-renewal. Downstream of
HSCs, the common lymphoid progenitors
(CLPs) may also be regulated by Batf,
which is highly expressed in these cells
and increases with age. A comparative
analysis of Batf-induced DNA-damage
responses in downstream hematopoietic
progenitors may shed light on the differ-
ences in lymphoid and myeloid potential
that underlie hematopoietic aging. We
postulate that age-associated Batf induc-
tion of a p53-dependent DNA-damage re-
sponse in CLPs could be robust and may
ultimately underlie the loss of lymphoid
compartment during aging.
In summary, the age-associated in-
crease in Batf could represent a fail-safe
mechanism to restrict the propagationnc.and expansion of defective HSC clones
through the induction of differentiation to
the lymphoid lineage. Moreover, with the
identification of Batf as an inducer of a
p53-dependent DNA-damage response,
therapies aimed at manipulating Batf
levels or activity could play a role in dis-
ease management or cancer therapy.REFERENCES
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